C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 195/1.11
C12N 15/13 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2022273
X-7581 Abstract The present invention discloses novel chimeric monoclonal antibodies, directed against proteoglycans of human melanoma cells, having antigen-specific variable regions of defined amino acid sequences. DNA constructs for the light and heavy chain variable regions comprising the novel antibodies of the invention are provided. Eukaryotic host cells capable of expression of the chimeric antibodies and comprising the novel chimeric antibody-encoding DNA constructs are also provided.
Beavers Lisa S.
Bumol Thomas F.
Gadski Robert A.
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Chimeric antibodies directed against a human glycoprotein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric antibodies directed against a human glycoprotein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric antibodies directed against a human glycoprotein... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1669630